 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2016, vol. 22, issue 3
Subject Area: Medicine
Pages: 1301-1307
DOI: 10.5272/jimab.2016223.1301
Published online: 19 September 2016
J of IMAB 2016 Jul-Sep;22(3):1301-1307
PERCUTANEOUS NEEDLE APONEUROTOMY AND LIPOGRAFT FOR DUPUYTREN’S DISEASE- OUR EXPERIENCE IN FOUR WEEKS FOLLOW UP
Bilyana Bozhanina 
, Ruslan Popstefanov,
Department of Orthopedics and Traumatology "St. Anna" University Hospital of Varna, Bulgaria.
ABSTRACT:
Background: Dupuytren‘s disease is progressive disorder, which affects the palmar fascia and results in irreversible flexion posture of the fingers. Etiology is unknown and significant risk factors include old age, male sex, white northern European extraction, presence of positive family history of Dupuytren’s disease, and diabetes mellitus.[1] Treatment is mainly surgical resection but it carries a long recovery period and significant rate of complications.
Objective: To present our experience with a minimally invasive technique of percutaneous needle aponeurotomy (PNA) and lipografting
Methods: The procedure of PNA and lipografting consists of percutaneus needle aponeurotomy, which is Lermisiaux modified technique and subdermal lipofilling. After the contracture release using a small hypodermic needle we inject the space between subcutaneous tissue and fascial cord with autologous lipoaspirate. We treated 15 patients with 22 rays. Primary outcome measures were total passive extension deficit improvement at one week and 4th weeks.
Results: The average total passive extension deficit (TPED) before treatment measured 86,33° at ray and postoperative mean TPED measured 22,13°.Immediately after release the mean flexion contracture correction of metacarpophalangeal (MCP) joint was from 44,33° to 1,38° degrees with 100% improvement rate. For proximal interphalangeal (PIP) joint the mean flexion contracture correction was from 51,25° to 23,75°. Patients were able to return to their normal activities after one week. We met only minor complications.
Conclusion: The procedure is minimally invasive and has short recovery time. It provides the possibility of treating multiple rays ‘s and the hand as a whole with no major complications.
Key words: Dupuytren’s disease, contracture, percutaneous needle aponeurotomy, lipograft,
- Download FULL TEXT /PDF 2812 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Bozhanina B, Popstefanov R. Percutaneous needle aponeurotomy and lipograft for Dupuytren’s disease- our experience in four weeks follow up. J of IMAB. 2016 Jul-Sep;22(3):1301-1307.
DOI: http://dx.doi.org/10.5272/jimab.2016223.1301.
Correspondence to: Bilyana Bozhanina MD, Department of Orthopedics and Traumatology "St. Anna" University Hospital of Varna; 100 Tsar Osvoboditel Blvd, 9000, Varna , Bulgaria; E-mail: bozhanina@abv.bg
REFERENCES:
1. Bayat A, McGrouther DA. Management of Dupuytren’s disease--clear advice for an elusive condition. Ann R Coll Surg Engl. 2006 Jan;88(1):3-8. [PubMed]
2. Denkler K. Surgical complications associated with fasciectomy for dupuytren’s disease: a 20-year review of the English literature. Eplasty. 2010 Jan 27;10:e15. [PubMed]
3. Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg Am. 2012 Apr;37(4):651-6. [PubMed]
4. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002 Sep;27(5):788-98. [PubMed]
5. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009 Sep 3;361(10):968-79. [PubMed]
6. van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012 Feb;129(2):469-77. [PubMed]
7. Hovius SE, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg. 2011 Jul;128(1):221-8. [PubMed]
8. McFarlane RM, Botz FS, Cheung H. Epidemiology of surgical patients. In: McFarlane RM, McGrouther DA, Flint M, editors. Dupuytren's Disease Biology and Treatment. Edinburgh: Churchill Livingstone; 1990. pp. 201–13.
9. Descatha A, Carton M, Mediouni Z, Dumontier C, Roquelaure Y, Goldberg M, et al. Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL). BMJ Open. 2014 Jan 29;4(1):e004214. [PubMed]
10. Weinzweig N, Culver JE, Fleegler EJ. Severe contractures of the proximal interphalangeal joint in Dupuytren's disease: combined fasciectomy with capsuloligamentous release versus fasciectomy alone. Plast Reconstr Surg. 1996 Mar;97(3):560-6. [PubMed]
11. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006 May-Jun;31(5):717-25. [PubMed]
12. Bergenudd H, Lindgдrde F, Nilsson BE. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. J Hand Surg Br. 1993 Apr;18(2):254-7. [PubMed]
13. Shih B, Brown JJ, Armstrong DJ, Lindau T, Bayat A. Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue. Hand (N Y). 2009 Sep;4(3):294-301. [PubMed]
14. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch. 2009 Apr;76(2):56-66. [PubMed]
15. Rigotti G, Marchi A, Galie M, Baroni G, Benati D, Krampera M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007 Apr 15;119(5):1409-22. [PubMed]
16. Koh YG, Choi YJ, Kwon SK, Kim YS, Yeo JE. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1308-16. [PubMed]
17. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol. 2003 Oct;183(2):355-66. [PubMed]
18. Verhoekx JS, Mudera V, Walbeehm ET, Hovius SE. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease. Plast Reconstr Surg. 2013 Nov;132(5):1139-48. [PubMed]
19. Degreef I, De Smet L. Cellulose Implants in Dupuytren’s Surgery. In: Eaton C, Seegenschmiedt H, Bayat A, Gabbiani G, Werker P, Wach W, eds. Dupuytren’s Disease and Related Hyperproliferative Disorders. Springer Berlin Heidelberg. 2012; Chapter:207-211. [CrossRef].
Received: 14 June 2016
Published online: 19 September 2016